Bonus BioGroup Ltd.
BONS
Rank in Stocks
#22088
Bonus BioGroup Ltd. is a clinical-stage biotechnology firm dedicated to... Bonus BioGroup Ltd. is a clinical-stage biotechnology firm dedicated to creating therapeutic solutions through tissue engineering and cell-based therapies. Their flagship products include BonoFill, which is developed for regenerating bone tissue in maxillofacial and orthopedic applications, and MesenCure, aimed at treating COVID-19 patients suffering from pneumonia and acute respiratory distress syndrome (ARDS), as well as other life-threatening acute inflammatory illnesses. The company's innovation pipeline encompasses bone augmentation treatments for individuals with osteoporosis, cutting-edge nano-materials for drug delivery systems, and advancements in vascularized bone and soft tissue grafts. Originally known as Oceana Advanced Industries Ltd., the company was founded in 1981 and operates from Haifa, Israel.
Share Price
$0.05001915
Last synced: 2026-11-09
Market Cap
$58.42M
Change (1 day)
0.86%
Change (1 year)
-24.70%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Bonus BioGroup Ltd. (BONS)
Category
Healthcare
EPS for Bonus BioGroup Ltd. (BONS)
EPS as of June 2026 TTM: $0.00
According to Bonus BioGroup Ltd.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Bonus BioGroup Ltd. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -67.00% |
| 2025 | $-0.01 | 76.92% |
| 2024 | $-0.01 | -4.41% |
| 2023 | $-0.01 | -61.58% |
| 2022 | $-0.02 | -65.56% |
| 2021 | $-0.05 | 678.79% |
| 2020 | $-0.01 | -13.16% |
| 2019 | $-0.01 | 22.58% |
| 2018 | $-0.01 | -13.89% |
| 2017 | $-0.01 | -59.78% |
| 2016 | $-0.02 | 11.18% |
| 2015 | $-0.02 | 12.59% |
| 2014 | $-0.01 | -10.63% |
| 2013 | $-0.02 | -29.52% |
| 2012 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -474,645.45% |
US
|
|
| $-7.07 | 214,142.42% |
US
|
|
| $-5.29 | 160,203.03% |
AU
|
|
| $12.88 | -390,406.06% |
BE
|
|
| $21.56 | -653,433.33% |
NL
|
Questions about Bonus BioGroup Ltd.'s earnings per share (EPS)
What is Bonus BioGroup Ltd.'s earnings per share (EPS)?
Bonus BioGroup Ltd.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Bonus BioGroup Ltd.'s earnings per share (EPS) in 2025?
In 2025, Bonus BioGroup Ltd.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Bonus BioGroup Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bonus BioGroup Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2021 ($-0.05).
How does Bonus BioGroup Ltd.'s earnings per share (EPS) compare with similar companies?
Bonus BioGroup Ltd.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.